Navigation Links
New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
Date:3/17/2008

dy of Intra-arterial (Ophthalmic Artery) Chemotherapy for Intraocular Retinoblastoma," can be found at http://www.SIRmeeting.org.

About Retinoblastoma

In the United States, about 300 children and adolescents are diagnosed with retinoblastoma each year, with almost two-thirds (63 percent) of all cases occurring before the age of two years, according to National Cancer Institute statistics. Retinoblastoma tumors start in the retina, the very back portion of the eye; they are caused by a gene mutation and occur once in every 15,000 to 16,000 births. In most cases, the mutation occurs in a single cell in the eye, so only that eye develops a tumor. Scientists do not yet know why these sporadic mutations occur. If left untreated, the tumors can spread to the brain via the optic nerve. One-half of the children in the world who develop this cancer will die.

About Intra-arterial Chemotherapy

Each interventional chemotherapy treatment is performed with the child asleep (under general anesthesia). An artery is punctured at the groin and a microcatheter (a tiny plastic tube) is threaded up into the artery of the affected eye. The chemotherapy drug, Melphalan, is injected, so the eye receives a large dose of the drug while the rest of the body receives a small dose. The retinoblastoma is very sensitive to Melphalan, and the eye tolerates the drug well while the rest of the body receives a non-toxic dose. Three intra-arterial chemotherapy treatments are usually sufficient; however, physicians have given up to six treatments.

About the Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter
'/>"/>

SOURCE Society of Interventional Radiology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. St. Jude Finds Signaling System That Halts the Growth of a Childhood Brain Cancer
4. Lung Cancer Alliance Commends NCCN on Screening Guidelines
5. Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
6. Anti-Cancer Drug CYT997 Update
7. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
8. Progen Announces Commencement of Global Phase 3 Study for PI-88 in Post- Resection Liver Cancer
9. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
10. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
11. GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., , KING OF PRUSSIA, Pa., Nov. 30 /PRNewswi...ed the completion of a Phase I study of CPSI-2364,...e production of TNF-alpha and other pro-inflammato...ity dose escalation study in healthy volunteers co...cal testing. ,, All 30 enrolled subjects comp...
(Date:11/30/2009)..., , WALTHAM, Mass., Nov. 30 /PRNewswir..., the global authority on medical technology marke...ial injectable market declined by almost 5% over 2... as a result of the economic crisis. The market wi...will return to the strong pre-recession growth rat...
(Date:11/30/2009)..., , ATLANTA, Nov. 30 Amoe...urgery breast care products, is sponsoring the 4th...or the first time, Amoena will honor survivors and... by awarding a cabin for the one with the most ins...test, Amoena wants to hear about young mothers who...
Breaking Medicine Technology:Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 1TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 2TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 3TGen led team is 1 of 7 selected for 241 million skin cancer grants 53469 4Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 1Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 2Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Low 53464 3URL Pharma Acquires PharmPro Manufacturing Facility and Equipment 53460 1URL Pharma Acquires PharmPro Manufacturing Facility and Equipment 53460 2
...nte Carlo brings predictability to whole range ...s, WAYLAND, Mass., Sept. 4 Tourtellotte Solution...ply chain software for the,biopharmaceutical, reta...,the release of its tcVisualize(TM) 3.0 clinical t...ualize software now offers wide support for variab...
...itional very late stent thrombosis, NATICK, Mass....orporation (NYSE: BSX ) today announced five-year...l, demonstrating continued,long-term safety and ef...ystem. Among the findings, the TAXUS stent showed ...and five, while the bare-metal control,experienced...
Other Medicine Technology:Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator 2Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 2Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 3Five-Year Data From Taxus II Clinical Trial Highlights Safety and Efficacy of Taxus(R) Stent Compared to Bare-Metal Stent 4
(Date:11/30/2009)...ease Control and Prevention estimate that well ove...cted with HIV/AIDS. New research from North Caroli...ted are minorities and do not have health insuranc... to facilitate education and prevention efforts in...arch, which analyzed 90,000 HIV patient hospital v...
(Date:11/30/2009)...Author of "My Two-Year Old Eats Octopus,"...e to eat everything. , (P...er in your house? Do you find yourself acting as ...nline videos – one focusing on packing lunch...wers for real-life parents’ questions &ndash...
(Date:11/30/2009)..., Colo., Nov. 30 Baxa Corporation ...ng what "culture of safety" means in today,s pharm...n, "Creating a Culture of Safety in Pharmacy ," f...cussing their experiences with culture of safety, ...macy and the role of technology in enabling or inh...
(Date:11/30/2009)...h., Nov. 30 Stryker Corp...e agreement to acquire privately held Ascent Heal...processing and remanufacturing of medical devices ...t, Stryker will acquire Ascent Healthcare Solution... closing is conditioned on the expiration or termi...
(Date:11/30/2009)...d treating a tumor without disturbing normal tissu...e therapies can be invasive and harsh. , Researc...d a way they might deliver the right therapy direc...mers, which specifically bind to living tumor tiss...a rodent with liver cancer until they found the be...
Breaking Medicine News(10 mins):Health News:Research highlights need for national HIV strategy 2Health News:New Videos Help Parents of Picky Eaters 2Health News:New Videos Help Parents of Picky Eaters 3Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 2Health News:Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned 3Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3Health News:First live targeting of tumors with RNA-based technology 2Health News:First live targeting of tumors with RNA-based technology 3
...er Orthopedic Group, Inc. announced today that Vin...e Vice President and Chief Growth Officer, effecti... Chief Executive Officer Thomas F. Kirk, Asar will...ching new businesses consistent with the company,s...
...d Corporation (Rite Aid) and nine of its subsidiar...in civil penalties to settle allegations of violat...epartment of Justice announced today. , , In add...to ensure compliance with all requirements of the ...
...ide relief from neuropathic pain , The pain that...ed by the trauma of amputation, entrapment, and co... extremely debilitating, and treatments show limit...ibutors to the pain. However, Halina Machelska and...
...immer Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH) anno...p;T,Corporation executive, has been appointed to i... serves on the boards of three other publicly trad...y regulated,markets," said John L. McGoldrick, Cha...
...Unite Americans in Fighting the Country,s Most Com...s Foundation today announces the launch of Let,s ...mprove the quality of life of the one-in-five Amer...s Move Together is designed to inspire people to ...
...eotaxis, Inc.,(Nasdaq: STXS ) today announced th...g the RF PowerAssert(TM) Magnetic Guidewire. Clea...08, the RF PowerAssert guidewire is the only,magne...ve solution that enables precise intra-lesion cont...
Other Medicine News:Health News:Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 3Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 4Health News:JCI online early table of contents: Jan. 12, 2009 2Health News:JCI online early table of contents: Jan. 12, 2009 3Health News:JCI online early table of contents: Jan. 12, 2009 4Health News:JCI online early table of contents: Jan. 12, 2009 5Health News:Zimmer Holdings Names Betsy Bernard to Board of Directors 2Health News:Zimmer Holdings Names Betsy Bernard to Board of Directors 3Health News:Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis 2Health News:Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis 3Health News:Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire 2Health News:Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire 3